| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
OSSR Stock Overview
Össur hf., together with its subsidiaries, designs, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
Össur hf Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.40.15 |
| 52 Week High | kr.49.85 |
| 52 Week Low | kr.38.20 |
| Beta | 0.71 |
| 1 Month Change | -5.64% |
| 3 Month Change | -7.06% |
| 1 Year Change | -12.91% |
| 3 Year Change | 30.36% |
| 5 Year Change | 67.29% |
| Change since IPO | 630.00% |
Recent News & Updates
Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Today we will run through one way of estimating the intrinsic value of Össur hf. ( CPH:OSSR ) by taking the expected...
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Is Össur hf (CPH:OSSR) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Does the August share price for Össur hf. ( CPH:OSSR ) reflect what it's really worth? Today, we will estimate the...
Shareholder Returns
| OSSR | DK Medical Equipment | DK Market | |
|---|---|---|---|
| 7D | -5.3% | -3.1% | -1.4% |
| 1Y | -12.9% | -3.6% | 6.9% |
Return vs Industry: OSSR underperformed the Danish Medical Equipment industry which returned -3.6% over the past year.
Return vs Market: OSSR underperformed the Danish Market which returned 6.9% over the past year.
Price Volatility
| OSSR volatility | |
|---|---|
| OSSR Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DK Market | 10.2% |
| 10% least volatile stocks in DK Market | 3.1% |
Stable Share Price: OSSR is less volatile than 75% of Danish stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: OSSR's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | 3,500 | Jon Sigurdsson | https://www.ossur.com |
Össur hf., together with its subsidiaries, designs, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers prosthetics products, including artificial limbs and related products for amputees; and lower and upper limb prosthetic components, including feet, knees, hands, fingers, liners, and other components. The company also provides bracing and supports products, such as supporting devices for spinal, knee, hip, foot, ankle, and hands that are primarily used to support joints and other body parts for therapeutic and preventative purposes; and injury solutions to enhance the healing process of bone and soft tissue injuries.
Össur hf Fundamentals Summary
| OSSR fundamental statistics | |
|---|---|
| Market Cap | US$2.58b |
| Earnings (TTM) | US$49.85m |
| Revenue (TTM) | US$700.70m |
51.8x
P/E Ratio3.7x
P/S RatioIs OSSR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OSSR income statement (TTM) | |
|---|---|
| Revenue | US$700.70m |
| Cost of Revenue | US$256.51m |
| Gross Profit | US$444.19m |
| Expenses | US$394.34m |
| Earnings | US$49.85m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
Feb 01, 2022
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 63.39% |
| Net Profit Margin | 7.11% |
| Debt/Equity Ratio | 55.4% |
How did OSSR perform over the long term?
See historical performance and comparisonValuation
Is Össur hf undervalued compared to its fair value and its price relative to the market?
10.4%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: OSSR (DKK40.15) is trading below our estimate of fair value (DKK44.82)
Significantly Below Fair Value: OSSR is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: OSSR is poor value based on its PE Ratio (51.8x) compared to the Danish Medical Equipment industry average (43x).
PE vs Market: OSSR is poor value based on its PE Ratio (51.8x) compared to the Danish market (16.6x).
Price to Earnings Growth Ratio
PEG Ratio: OSSR is poor value based on its PEG Ratio (2.6x)
Price to Book Ratio
PB vs Industry: OSSR is good value based on its PB Ratio (4.3x) compared to the DK Medical Equipment industry average (9x).
Future Growth
How is Össur hf forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
20.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OSSR's forecast earnings growth (20.3% per year) is above the savings rate (0.1%).
Earnings vs Market: OSSR's earnings (20.3% per year) are forecast to grow faster than the Danish market (8.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: OSSR's revenue (7.1% per year) is forecast to grow faster than the Danish market (6.3% per year).
High Growth Revenue: OSSR's revenue (7.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OSSR's Return on Equity is forecast to be low in 3 years time (13%).
Past Performance
How has Össur hf performed over the past 5 years?
-9.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: OSSR has a large one-off loss of $22.7M impacting its September 30 2021 financial results.
Growing Profit Margin: OSSR's current net profit margins (7.1%) are higher than last year (3.1%).
Past Earnings Growth Analysis
Earnings Trend: OSSR's earnings have declined by 9.8% per year over the past 5 years.
Accelerating Growth: OSSR's earnings growth over the past year (152%) exceeds its 5-year average (-9.8% per year).
Earnings vs Industry: OSSR earnings growth over the past year (152%) exceeded the Medical Equipment industry 45.3%.
Return on Equity
High ROE: OSSR's Return on Equity (8.5%) is considered low.
Financial Health
How is Össur hf's financial position?
Financial Position Analysis
Short Term Liabilities: OSSR's short term assets ($335.0M) exceed its short term liabilities ($200.5M).
Long Term Liabilities: OSSR's short term assets ($335.0M) do not cover its long term liabilities ($441.2M).
Debt to Equity History and Analysis
Debt Level: OSSR's net debt to equity ratio (41.8%) is considered high.
Reducing Debt: OSSR's debt to equity ratio has increased from 36.4% to 55.4% over the past 5 years.
Debt Coverage: OSSR's debt is well covered by operating cash flow (22.8%).
Interest Coverage: OSSR's interest payments on its debt are well covered by EBIT (8.4x coverage).
Balance Sheet
Dividend
What is Össur hf current dividend yield, its reliability and sustainability?
0.48%
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate OSSR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate OSSR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if OSSR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if OSSR's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: OSSR is not paying a notable dividend for the Danish market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of OSSR's dividend in 3 years as they are not forecast to pay a notable one for the Danish market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
5.9yrs
Average management tenure
CEO
Jon Sigurdsson (65 yo)
26yrs
Tenure
US$1,449,000
Compensation
Mr. Jon Sigurdsson serves as CEO & President at Össur hf. He has been the Chief Executive Officer and President of Gibaud SAS since 1996. Mr. Sigurdsson has been Senior Vice President of Procurement at Pro...
CEO Compensation Analysis
Compensation vs Market: Jon's total compensation ($USD1.45M) is about average for companies of similar size in the Danish market ($USD1.38M).
Compensation vs Earnings: Jon's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: OSSR's management team is seasoned and experienced (5.9 years average tenure).
Board Members
Experienced Board: OSSR's board of directors are seasoned and experienced ( 13 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Össur hf.'s employee growth, exchange listings and data sources
Key Information
- Name: Össur hf.
- Ticker: OSSR
- Exchange: CPSE
- Founded: 1971
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: kr.16.952b
- Shares outstanding: 422.21m
- Website: https://www.ossur.com
Number of Employees
Location
- Össur hf.
- Grjothals 1-5
- Reykjavik
- 110
- Iceland
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/01/23 18:02 |
| End of Day Share Price | 2022/01/21 00:00 |
| Earnings | 2021/09/30 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.